Sigma Planning »

Intensity Therapeutics shares owned by Sigma Planning

Quarter-by-quarter ownership of Intensity Therapeutics (INTS) shares owned by Sigma Planning from 13F filings

Historical chart of Sigma Planning investment in Intensity Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intensity Therapeutics held by Sigma Planning consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intensity Therapeutics by Sigma Planning

Quarter filed Position value Share count Share price at filing
2024-03-31 $249k 48k 5.20
2023-12-31 $295k 34k 8.57
2023-09-30 $191k 48k 3.97

More positions owned by Sigma Planning

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Ishares Tr Core Div Grwth (DGRO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr S&p 500 Grwt Etf (IVW)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Ishares Tr Core S&p Mcp Etf (IJH)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Sigma Planning

Top funds holding Intensity Therapeutics

Sapient Capital
Vanguard Group
Brown Advisory Holdings Incorporated
Sigma Planning
Geode Capital Management
Mesirow Financial Investment Management International Equity
One Charles Private Wealth Services
Sentinus
Lakeview Capital Partners
Qube Research & Technologies
BlackRock
Commonwealth Equity Services
Jpmorgan Chase & Co
Tower Research Capital
UBS Group

View all funds holding Intensity Therapeutics